Free Trial

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Given Consensus Recommendation of "Hold" by Brokerages

DENTSPLY SIRONA logo with Medical background
Remove Ads

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) have been given an average recommendation of "Hold" by the fourteen research firms that are presently covering the company, Marketbeat.com reports. Eleven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $23.33.

Several brokerages recently weighed in on XRAY. StockNews.com downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Mizuho lowered their price target on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a report on Thursday, March 13th. Barrington Research cut their price objective on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating for the company in a report on Friday, February 28th. Wells Fargo & Company lowered their target price on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a report on Friday, February 28th. Finally, Morgan Stanley reduced their price target on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating on the stock in a report on Tuesday, December 17th.

View Our Latest Stock Report on XRAY

Remove Ads

Insiders Place Their Bets

In other news, Director Gregory T. Lucier purchased 15,142 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The stock was purchased at an average cost of $16.51 per share, with a total value of $249,994.42. Following the purchase, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.52% of the stock is owned by insiders.

Institutional Trading of DENTSPLY SIRONA

Several institutional investors have recently added to or reduced their stakes in XRAY. Treasurer of the State of North Carolina lifted its stake in shares of DENTSPLY SIRONA by 0.6% during the 4th quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier's stock worth $1,686,000 after acquiring an additional 560 shares during the last quarter. UMB Bank n.a. increased its stake in DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after purchasing an additional 564 shares during the period. MML Investors Services LLC lifted its position in shares of DENTSPLY SIRONA by 2.1% during the third quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier's stock worth $803,000 after purchasing an additional 620 shares during the last quarter. Blue Trust Inc. boosted its stake in shares of DENTSPLY SIRONA by 10.9% during the fourth quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier's stock valued at $137,000 after purchasing an additional 707 shares during the period. Finally, Quarry LP increased its stake in DENTSPLY SIRONA by 25.7% in the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after buying an additional 780 shares during the period. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Price Performance

NASDAQ:XRAY traded down $0.71 during trading hours on Wednesday, hitting $14.93. 2,436,694 shares of the stock traded hands, compared to its average volume of 3,093,060. The stock has a 50 day moving average price of $17.62 and a 200 day moving average price of $20.16. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The company has a market cap of $2.97 billion, a price-to-earnings ratio of -7.21, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA has a 1 year low of $14.78 and a 1 year high of $33.22.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.29%. DENTSPLY SIRONA's payout ratio is presently -14.07%.

DENTSPLY SIRONA Company Profile

(Get Free Report

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Stories

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Donald Trump Owns These 7 Stocks, Should You?

Donald Trump Owns These 7 Stocks, Should You?

He’s one of the most talked-about billionaires in the world—but when it comes to investing, Donald Trump’s stock picks are shockingly… low-key.

Related Videos

Donald Trump Owns These 7 Stocks, Should You?
Donald Trump Owns These 7 Stocks, Should You?
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads